Live Breaking News & Updates on Timothy Mayleben

Stay updated with breaking news from Timothy mayleben. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Esperion Therapeutics Inc (ESPR) Q1 2021 Earnings Call Transcript


Operator
Ladies and gentlemen, thank you for standing by, and welcome. [Operator Instructions] I would now like to hand the conference over to Ben Church, Investor Relations and Corporate Communications at Esperion. Please go ahead, sir.
Benjamin Church
Head, Corporate Communications & Investor Relations
Thank you, operator. Good afternoon and welcome to Esperion s First Quarter 2021 Financial Results and Company Update Conference Call. I m Ben Church, and I m responsible for Investor Relations and Corporate Communications here at Esperion. With me on today s call are Tim Mayleben, President and Chief Executive Officer; Sheldon Koenig, Chief Operating Officer; and Rick Bartram, Chief Financial Officer. I want to remind callers that the information discussed on the call today is covered under the Safe Harbor provisions of the Private Securities Litigation Reform Act. I caution listeners that management will be making forward-looking statements. Actual results cou ....

United States , Timothy Mayleben , Daiichi Sankyo , Rick Bartram , Sheldon Koenig , Peter Toth , Michael Yee Jefferies , Michael Yee , Richard Bartram , Tim Mayleben , Company Update Conference Call , Esperion Therapeutics Inc , Ben Church , Corporate Communications Investor Relations , Im Ben Church , American Society For Preventive Cardiology , Ut Southwestern Medical Center , Benjamin Church Head , Corporate Communications , Corporate Communications At Esperion , Investor Relations , First Quarter , Company Update Conference , Chief Executive Officer , Chief Operating Officer , Chief Financial ,

Esperion Therapeutics Inc (ESPR) Q4 2020 Earnings Call Transcript


Esperion Therapeutics Inc (ESPR) Q4 2020 Earnings Call Transcript
Motley Fool Transcribers
© The Motley Fool
Logo of jester cap with thought bubble.
Esperion Therapeutics Inc (NASDAQ: ESPR)
Popular Searches
Operator
Ladies and gentlemen, thank you for standing by, and welcome. [Operator Instructions] Please be advised that today s conference call may be recorded. I would now like to hand the conference call over to Ben Church, Investor Relations and Corporate Communications at Esperion. Please go ahead, sir.
This article is a transcript of this conference call produced for The Motley Fool. While we strive for our Foolish Best, there may be errors, omissions, or inaccuracies in this transcript. As with all our articles, The Motley Fool does not assume any responsibility for your use of this content, and we strongly encourage you to do your own research, including listening to the call yourself and reading the company s SEC fili ....

Rick Bartram , Daiichi Sankyo Europe , Sheldon Koenig , Derek Archila , Julian Harrison , Joseph Thome Cowen , Joseph Thome , Michael Yee , Richard Bartram , Tim Mayleben , Geoff Meacham , Olivia Brayer , America Merrill Lynch , Timothy Mayleben , Daiichi Sankyo , Martin Auster , Tom Shrader , Michael Yee Jefferies , Paul Choi , Company Update Conference Call , Esperion Therapeutics Inc , Goldman Sachs , Credit Suisse , Ben Church , Corporate Communications Investor Relations , Motley Fool Esperion Therapeutics Inc ,